JP2005527558A5 - - Google Patents

Download PDF

Info

Publication number
JP2005527558A5
JP2005527558A5 JP2003579837A JP2003579837A JP2005527558A5 JP 2005527558 A5 JP2005527558 A5 JP 2005527558A5 JP 2003579837 A JP2003579837 A JP 2003579837A JP 2003579837 A JP2003579837 A JP 2003579837A JP 2005527558 A5 JP2005527558 A5 JP 2005527558A5
Authority
JP
Japan
Prior art keywords
group
compound
formulation
hydrogen
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003579837A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005527558A (ja
Filing date
Publication date
Priority claimed from US10/105,826 external-priority patent/US20030195175A1/en
Application filed filed Critical
Publication of JP2005527558A publication Critical patent/JP2005527558A/ja
Publication of JP2005527558A5 publication Critical patent/JP2005527558A5/ja
Pending legal-status Critical Current

Links

JP2003579837A 2002-03-25 2003-03-12 新しい骨の形成を誘導するための炭素−2−修飾−19−ノル−ビタミンd類似化合物の使用 Pending JP2005527558A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/105,826 US20030195175A1 (en) 2002-03-25 2002-03-25 Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone
PCT/US2003/007443 WO2003082300A1 (en) 2002-03-25 2003-03-12 Use of carbon-2-modified-vitamin d analogs to induce the formation of new bone

Publications (2)

Publication Number Publication Date
JP2005527558A JP2005527558A (ja) 2005-09-15
JP2005527558A5 true JP2005527558A5 (enExample) 2006-04-06

Family

ID=28673538

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003579837A Pending JP2005527558A (ja) 2002-03-25 2003-03-12 新しい骨の形成を誘導するための炭素−2−修飾−19−ノル−ビタミンd類似化合物の使用

Country Status (20)

Country Link
US (3) US20030195175A1 (enExample)
EP (1) EP1494680B1 (enExample)
JP (1) JP2005527558A (enExample)
KR (1) KR100983953B1 (enExample)
CN (1) CN100531739C (enExample)
AT (1) ATE406901T1 (enExample)
AU (1) AU2003220169B2 (enExample)
BR (1) BR0308701A (enExample)
CA (1) CA2480125C (enExample)
DE (1) DE60323351D1 (enExample)
DK (1) DK1494680T3 (enExample)
ES (1) ES2312764T3 (enExample)
HK (1) HK1079996B (enExample)
IL (1) IL164275A0 (enExample)
MX (1) MXPA04009288A (enExample)
NZ (1) NZ535843A (enExample)
PL (1) PL372346A1 (enExample)
PT (1) PT1494680E (enExample)
WO (1) WO2003082300A1 (enExample)
ZA (1) ZA200408153B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2539361A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an estrogen agonist/antagonist
KR20060040744A (ko) * 2003-09-19 2006-05-10 화이자 프로덕츠 인크. 쇠약, 근육 손상 또는 근육감소증 치료용2-알킬리덴-19-노르-비타민 d 유도체
WO2005027928A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. 2-alkylidene-19-nor-vit amin d derivatives for the treatment of hypocalcemic tetany or hyproparathyroidism
WO2005027919A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. 2-alkylidene-19-nor-vitamin d derivatives for the treatment of a second hip fracture
AU2004273667A1 (en) * 2003-09-19 2005-03-31 Wisconsin Alumni Research Foundation (Warf) 2-alkylidene-19-nor-vitamin D derivatives for the treatment of osteopenia or male osteoporosis
US7214671B2 (en) * 2004-02-19 2007-05-08 Wisconsin Alumni Research Foundation Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 for the prophylaxis of bone diseases
EP1743023A1 (en) * 2004-05-07 2007-01-17 Wisconsin Alumni Research Foundation Method of forming mesenchymal stem cells from embryonic stem cells
WO2006061683A1 (en) * 2004-12-09 2006-06-15 Pfizer Products Inc. 2-alkylidene-19-nor-vitamin d derivatives for the treatment of osteogenesis imperfecta
US7528122B2 (en) 2006-02-02 2009-05-05 Wisconsin Alumni Research Foundation Vitamin D analog—NEL, methods and uses thereof
US7803789B2 (en) * 2006-02-02 2010-09-28 Wisconsin Alumni Research Foundation Vitamin D analog—RAK, methods and uses thereof
NZ595727A (en) * 2009-04-17 2013-11-29 Vidasym Inc Vitamin d receptor agonists and uses thereof
US9688596B2 (en) * 2015-08-05 2017-06-27 Wisconsin Alumni Research Foundation Synthesis and biological activity of 2-methylene analogs of calcitriol and related compounds
CN111588506B (zh) * 2020-01-02 2022-01-25 南京医科大学 一种含维生素c的钛种植体存储液的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US584928A (en) * 1897-06-22 Schlag
US4666634A (en) * 1984-12-05 1987-05-19 Chugai Seiyaku Kabushiki Kaisha vitamin D3 derivatives having a substituent at 2-position
IL74617A (en) * 1985-03-15 1988-11-15 Yeda Res & Dev Compositions comprising a vitamin d derivative and method for the local treatment of bone fractures in animals
US5246925A (en) * 1989-03-09 1993-09-21 Wisconsin Alumni Research Foundation 19-nor-vitamin D compounds for use in treating hyperparathyroidism
CA1333616C (en) * 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds
US5556645A (en) * 1990-01-12 1996-09-17 Bockman; Richard Methods of enhancing wound healing and tissue repair
US5086191A (en) * 1991-05-28 1992-02-04 Wisconsin Alumni Research Foundation Intermediates for the synthesis of 19-nor vitamin D compounds
JP2898882B2 (ja) * 1993-04-05 1999-06-02 ウイスコンシン アラムナイ リサーチ フオンデーシヨン 2−位に置換基を有する19−ノル−ビタミンd3 化合物
US5565589A (en) * 1993-11-03 1996-10-15 Wisconsin Alumni Research Foundation 17-formyl-5,6-trans-vitamin D compounds
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
WO1997011053A1 (en) * 1995-09-21 1997-03-27 Wisconsin Alumni Research Foundation Calcitriol derivatives and their uses
US5976142A (en) * 1996-10-16 1999-11-02 Chin; Martin Apparatus and method for distraction osteogenesis of small alveolar bone
US5945410A (en) * 1997-03-17 1999-08-31 Wisconsin Alumni Research Foundation 2-alkyl-19-nor-vitamin D compounds
US5843928A (en) * 1997-03-17 1998-12-01 Wisconsin Alumni Research Foundation 2-alkylidene-19-nor-vitamin D compounds
US6392071B1 (en) * 1997-03-17 2002-05-21 Wisconsin Alumni: Research Foundation 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
US6306844B1 (en) * 1997-03-17 2001-10-23 Wisconsin Alumni Research Foundation Use of 2α-methyl-19-nor-20(S)-1α, 25-dihydroxyvitamin D3 to increase bone strength
CA2297489A1 (en) * 1997-07-30 1999-02-11 Emory University Novel bone mineralization proteins, dna, vectors, expression systems
EP1301189A2 (en) * 2000-07-14 2003-04-16 Wisconsin Alumni Research Foundation USE OF 2-METHYLENE-19-NOR-20(S)-1$g(a),25-DIHYDROXYVITAMIN D 3? TO INCREASE BONE STRENGTH

Similar Documents

Publication Publication Date Title
JP2005527558A5 (enExample)
Yan et al. Comparison of acellular dermal graft and palatal autograft in the reconstruction of keratinized gingiva around dental implants: a case report.
JP2004502638A5 (enExample)
AU9189301A (en) Use of substituted imidazo(1,2-A)pyridine-, imidazo(1,2-A)pyrimidine and imidazo(1,2-A)pyrazine-3-YL-amine derivatives for producing NOS-inhibiting medicaments
NO20071058L (no) Risedronatsammensetninger og deres fremgangsmater for anvendelse
JP2008526999A5 (enExample)
JP2007512376A5 (enExample)
DE60213404D1 (de) Verwendung von sulodexid zur behandlung von reizdarm
ATE301654T1 (de) Naphthyridinderivate
JP2005504092A5 (enExample)
JP2003532640A5 (enExample)
JP2007507494A5 (enExample)
RU2015115696A (ru) Соединения, предназначенные для лечения ожирения, и способы их применения
JP2004502732A5 (enExample)
RU2003134629A (ru) Соединения цефема
CA2480125A1 (en) Use of carbon-2-modified-19-nor-vitamin d analogs to induce the formation of new bone
RU2012150501A (ru) Противораковые стероидные лактоны, ненасыщенные в положении 7(8)
JP2007517037A5 (enExample)
CA2526244A1 (en) Pharmaceutical combination of g-csf and plgf useful for blood stem cell mobilization
JP2008520690A5 (enExample)
DE60216239T8 (de) Verwendung von Cyclohexenon-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Dysurie
RU2005128831A (ru) Обладающие противоопухолевым действием 2-замещенные эстра-1,3,5( 10 )-триен-3-илсульфаматы
JP2005529067A5 (enExample)
CA2443235A1 (en) Pharmaceutical compositions comprising ascomycin
US20060177517A1 (en) Antiinflammtory agent and antiinflammatory medical material